Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $517.65 | Total: $2,588.25 |
| 1 | 10 | $438.48 | Total: $4,384.80 |
| 1 | 25 | $371.49 | Total: $9,287.25 |
| 1 | 50 | $316.68 | Total: $15,834.00 |
| 1 | 100 | $274.05 | Total: $27,405.01 |
Overview
CP-642931 (Sorbitol dehydrogenase-IN-1) is an orally active and highly potent sorbitol dehydrogenase inhibitor for the study of diabetes and cardiovascular disease.
Chemical Properties
| Molecular Formula | C17H25N7O |
| Molecular Weight | 343.43 |
| CAS Numbers | 300551-49-9 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C[C@@H]1N([C@H](C)CN(C1)C=2N=C(C)N=C(C)N2)C3=NC([C@@H](C)O)=NC=C3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Landau Z, Novotny MJ, Preston GM, Wright K, Freeman T, Dai H, Thompson J, Oates PJ, Calle RA. Pharmacokinetics, pharmacodynamics, tolerability, and safety of a novel sorbitol dehydrogenase inhibitor in healthy participants. J Clin Pharmacol. 2010 May;50[5] 521-30. doi 10.11770091270009336354. Epub 2010 Mar 10. PubMed PMID 20220044.